{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:39:35Z","timestamp":1776335975207,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Liaoning Provincial Natural Science Foundation of China","award":["2025-BS-0559"],"award-info":[{"award-number":["2025-BS-0559"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11792-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:39:24Z","timestamp":1776332364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melatonin inhibits malignant biological behaviors in carboplatin-resistant ovarian cancer cells: elucidating the potential molecular mechanisms"],"prefix":"10.1007","volume":"53","author":[{"given":"Xiaoying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"10","key":"11792_CR1","volume":"14","author":"UM Zamwar","year":"2022","unstructured":"Zamwar UM, Anjankar AP (2022) Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus 14(10):e30561","journal-title":"Cureus"},{"issue":"1","key":"11792_CR2","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A (2026) Cancer statistics, 2026. CA Cancer J Clin 76(1):e70043","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"11792_CR3","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8293","volume":"47","author":"L Yang","year":"2022","unstructured":"Yang L, Xie HJ, Li YY, Wang X, Liu XX, Mai J (2022) Molecular mechanisms of platinum\u2011based chemotherapy resistance in ovarian cancer (Review). Oncol Rep 47(4):82","journal-title":"Oncol Rep"},{"key":"11792_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C, De Felice F, Romito A, Iacobelli V, Sassu CM, Corrado G et al (2021) Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments. Semin Cancer Biol 77:144\u201366","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"11792_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2024.100009","volume":"35","author":"F Martorana","year":"2025","unstructured":"Martorana F, Pavone G, Sessa C, Treglia G, Lheureux S, Colombo I (2025) Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer. International journal of gynecological cancer\u202f: official journal of the International Gynecological Cancer Society 35(1):100009","journal-title":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society"},{"issue":"2","key":"11792_CR6","first-page":"Cd012007","volume":"2","author":"NY Ngoi","year":"2022","unstructured":"Ngoi NY, Syn NL, Goh RM, Goh BC, Huang RY, Soon YY et al (2022) Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer. Cochrane Database Syst Rev 2(2):Cd012007","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"11792_CR7","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.2174\/0929867329666220105115755","volume":"29","author":"M Pohanka","year":"2022","unstructured":"Pohanka M (2022) New uses of melatonin as a drug; a review. Curr Med Chem 29(20):3622\u20133637","journal-title":"Curr Med Chem"},{"issue":"3","key":"11792_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ph19030439","volume":"19","author":"M Butiulca","year":"2026","unstructured":"Butiulca M, Farczadi L, Veres M, Azamfirei L (2026) Analytical methods for melatonin quantification: advances, challenges, and clinical applications. Pharmaceuticals (Basel) 19(3):439","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"11792_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","volume":"15","author":"S Tordjman","year":"2017","unstructured":"Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N et al (2017) Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 15(3):434\u201343","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"11792_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/13813455.2020.1770799","volume":"128","author":"S Samanta","year":"2022","unstructured":"Samanta S (2022) Physiological and pharmacological perspectives of melatonin. Arch Physiol Biochem 128(5):1346\u20131367","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"11792_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.12793\/tcp.2022.30.e21","volume":"30","author":"HK Kim","year":"2022","unstructured":"Kim HK, Yang KI (2022) Melatonin and melatonergic drugs in sleep disorders. Transl Clin Pharmacol 30(4):163\u2013171","journal-title":"Transl Clin Pharmacol"},{"issue":"11","key":"11792_CR12","volume":"9","author":"N Ferlazzo","year":"2020","unstructured":"Ferlazzo N, Andolina G, Cannata A, Costanzo MG, Rizzo V, Curr\u00f2 M et al (2020) Is melatonin the cornucopia of the 21st century? Antioxidants (Basel, Switzerland) 9(11):1088","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"11792_CR13","doi-asserted-by":"crossref","unstructured":"Durak I, Durak B, Duzenli T, Yilmaz M, Kaya M, Sadecolak M et al (2026) Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality. Turk J Gastroenterol","DOI":"10.5152\/tjg.2026.25808"},{"issue":"1","key":"11792_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13048-019-0502-8","volume":"12","author":"H Zare","year":"2019","unstructured":"Zare H, Shafabakhsh R, Reiter RJ, Asemi Z (2019) Melatonin is a potential inhibitor of ovarian cancer: molecular aspects. J Ovarian Res 12(1):26","journal-title":"J Ovarian Res"},{"issue":"8","key":"11792_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02906-y","volume":"11","author":"S Bu","year":"2020","unstructured":"Bu S, Wang Q, Sun J, Li X, Gu T, Lai D (2020) Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE\/AKT\/\u03b2-catenin\/SLUG axis. Cell death & disease 11(8):644","journal-title":"Cell death & disease"},{"issue":"7","key":"11792_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.7150\/jca.14573","volume":"7","author":"M Zhao","year":"2016","unstructured":"Zhao M, Wan J, Zeng K, Tong M, Lee AC, Ding J et al (2016) The reduction in circulating melatonin level may contribute to the pathogenesis of ovarian cancer: a retrospective study. J Cancer 7(7):831\u20136","journal-title":"J Cancer"},{"issue":"10","key":"11792_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/carcin\/bgx054","volume":"38","author":"LGA Chuffa","year":"2017","unstructured":"Chuffa LGA, Reiter RJ, Lupi LA (2017) Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms. Carcinogenesis 38(10):945\u2013952","journal-title":"Carcinogenesis"},{"issue":"5","key":"11792_CR18","first-page":"801","volume":"31","author":"A Zem\u0142a","year":"2017","unstructured":"Zem\u0142a A, Grzegorek I, Dzi\u0119giel P, Jab\u0142o\u0144ska K (2017) Melatonin synergizes the chemotherapeutic effect of cisplatin in ovarian cancer cells independently of MT1 melatonin receptors. In vivo (Athens Greece) 31(5):801\u2013809","journal-title":"In vivo (Athens Greece)"},{"issue":"4","key":"11792_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.14715\/cmb\/2022.68.4.19","volume":"68","author":"S Baghal-Sadriforoush","year":"2022","unstructured":"Baghal-Sadriforoush S, Bagheri M, Abdi Rad I, Sotoodehnejadnematalahi F (2022) Melatonin sensitizes OVCAR-3 cells to cisplatin through suppression of PI3K\/Akt pathway. Cellular and molecular biology (Noisy-le-Grand, France) 68(4):158\u201369","journal-title":"Cellular and molecular biology (Noisy-le-Grand, France)"},{"issue":"1","key":"11792_CR20","first-page":"70","volume":"42","author":"M Sheng","year":"2016","unstructured":"Sheng M, Liu J, Liu J, Zou J (2016) Effect of melatonin combined with carboplatin on proliferation and apoptosis of ovarian cancer SKOV3 cells in vitro. J Jilin Univeristy Med Ed 42(1):70\u201375","journal-title":"J Jilin Univeristy Med Ed"},{"issue":"1","key":"11792_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-020-00439-w","volume":"21","author":"H Ma","year":"2020","unstructured":"Ma H, Qin Q, Mi J, Feng Q (2020) 1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function. BMC Pharmacol Toxicol 21(1):67","journal-title":"BMC Pharmacol Toxicol"},{"issue":"19","key":"11792_CR22","doi-asserted-by":"publisher","first-page":"23308","DOI":"10.18632\/aging.203623","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Kong L, Zhang Y, Wang C, Sun L (2021) Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells. Aging 13(19):23308\u201323327","journal-title":"Aging"},{"issue":"7","key":"11792_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073779","volume":"23","author":"L Wang","year":"2022","unstructured":"Wang L, Wang C, Choi WS (2022) Use of melatonin in cancer treatment: where are we? Int J Mol Sci 23(7):3779","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11792_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1590\/0004-282x-anp-2020-0379","volume":"79","author":"APR Bueno","year":"2021","unstructured":"Bueno APR, Savi FM, Alves IA, Bandeira VAC (2021) Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review. Arq Neuropsiquiatr 79(8):732\u2013742","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"11792_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00415-020-10381-w","volume":"269","author":"G Fatemeh","year":"2022","unstructured":"Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M (2022) Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol 269(1):205\u2013216","journal-title":"J Neurol"},{"issue":"5","key":"11792_CR26","first-page":"675","volume":"11","author":"K Seo","year":"2023","unstructured":"Seo K, Kim JH, Han D (2023) Effects of melatonin supplementation on sleep quality in breast cancer patients: a systematic review and meta-analysis. Healthc (Basel Switzerland) 11(5):675","journal-title":"Healthc (Basel Switzerland)"},{"key":"11792_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.sleep.2021.03.040","volume":"82","author":"A Jafari-Koulaee","year":"2021","unstructured":"Jafari-Koulaee A, Bagheri-Nesami M (2021) The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study. Sleep Med 82:96\u2013103","journal-title":"Sleep Med"},{"issue":"1","key":"11792_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.32598\/bcn.12.1.1650.2","volume":"12","author":"M Shahrokhi","year":"2021","unstructured":"Shahrokhi M, Ghaeli P, Arya P, Shakiba A, Noormandi A, Soleimani M et al (2021) Comparing the Effects of Melatonin and Zolpidem on Sleep Quality, Depression, and Anxiety in PatientsWithColorectalCancerUndergoingChemotherapy. Basic Clin Neurosci 12(1):105\u2013114","journal-title":"Basic Clin Neurosci"},{"issue":"7","key":"11792_CR29","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1007\/s11033-022-07448-4","volume":"49","author":"R Dixit","year":"2022","unstructured":"Dixit R, Pandey M, Rajput M, Shukla VK (2022) Unravelling of the comparative transcriptomic profile of gallbladder cancer using mRNA sequencing. Mol Biol Rep 49(7):6395\u20136403","journal-title":"Mol Biol Rep"},{"issue":"1","key":"11792_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09747-2","volume":"22","author":"S Zhu","year":"2022","unstructured":"Zhu S, Bao H, Zhang MC, Liu H, Wang Y, Lin C et al (2022) KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data. BMC Cancer 22(1):662","journal-title":"BMC Cancer"},{"key":"11792_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109312","volume":"116","author":"F Wang","year":"2023","unstructured":"Wang F, Man C, Wang X, Odle J, Maltecca C, Lin X (2023) MicroRNA and mRNA sequencing analyses reveal key hepatic metabolic and signaling pathways responsive to maternal undernutrition in full-term fetal pigs. J Nutr Biochem 116:109312","journal-title":"J Nutr Biochem"},{"issue":"1","key":"11792_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-019-0220-0","volume":"52","author":"T Viscarra","year":"2019","unstructured":"Viscarra T, Buchegger K, Jofre I, Riquelme I, Zanella L, Abanto M et al (2019) Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line. Biol Res 52(1):13","journal-title":"Biol Res"},{"key":"11792_CR33","doi-asserted-by":"crossref","unstructured":"Arend RC, Londo\u00f1o-Joshi AI, Straughn JM Jr., Buchsbaum DJ (2013) The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131(3):772\u20139","DOI":"10.1016\/j.ygyno.2013.09.034"},{"issue":"10","key":"11792_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101658","volume":"8","author":"M Teeuwssen","year":"2019","unstructured":"Teeuwssen M, Fodde R (2019) Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. J Clin Med 8(10):1658","journal-title":"J Clin Med"},{"issue":"11","key":"11792_CR35","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2174\/0929867330666230409141957","volume":"31","author":"A Davoodvandi","year":"2024","unstructured":"Davoodvandi A, Asemi R, Sharifi M, Reiter RJ, Matini SA, Mirhashemi SM et al (2024) Melatonin as a promising agent for cancer treatment: insights into its effects on the Wnt\/beta-catenin signaling pathway. Curr Med Chem 31(11):1315\u201331","journal-title":"Curr Med Chem"},{"issue":"1","key":"11792_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/03602532.2024.2305764","volume":"56","author":"YJ Yi","year":"2024","unstructured":"Yi YJ, Tang H, Pi PL, Zhang HW, Du SY, Ge WY et al (2024) Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery. Drug Metab Rev 56(1):62\u201379","journal-title":"Drug Metab Rev"},{"issue":"6","key":"11792_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/carcin\/bgac045","volume":"43","author":"CE Grant","year":"2022","unstructured":"Grant CE, Flis AL, Ryan BM (2022) Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis 43(6):517\u2013527","journal-title":"Carcinogenesis"},{"issue":"2","key":"11792_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1074\/jbc.M116.748970","volume":"292","author":"S Roy","year":"2017","unstructured":"Roy S, Lu K, Nayak MK, Bhuniya A, Ghosh T, Kundu S et al (2017) Activation of D2 dopamine receptors in CD133\u2009+\u2009ve cancer stem cells in non-small cell lung carcinoma inhibits proliferation, clonogenic ability, and invasiveness of these cells. J Biol Chem 292(2):435\u201345","journal-title":"J Biol Chem"},{"issue":"6","key":"11792_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/a-2226-3971","volume":"56","author":"K Kulsoom","year":"2024","unstructured":"Kulsoom K, Ali W, Saba Z, Hussain S, Zahra S, Irshad M et al (2024) Revealing Melatonin\u2019s Mysteries: Receptors, Signaling Pathways, and Therapeutics Applications. Horm Metab Res 56(6):405\u2013418","journal-title":"Horm Metab Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11792-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:39:29Z","timestamp":1776332369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11792-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11792"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11792-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"622"}}